share_log

科濟藥業-B：翌日披露報表

CARSGEN-B: Next Day Disclosure Return

HKEX ·  Jun 28 19:34

Summary by Futu AI

科濟藥業-B（02171.HK）於2024年6月28日提交了翌日披露報表，披露其已發行股份或庫存股份的變動情況。報告顯示，公司在2024年6月25日至6月28日期間，已發行股份數目保持不變，為575,653,415股。然而，在2024年5月31日至6月28日期間，公司進行了多次股份回購，總計回購股份數目為4,135,500股，佔已發行股份的0.7184%。最後一次回購發生在2024年6月28日，當日回購150,000股，每股購回價介於HKD 4.74至HKD 4.81之間，總支付價格為HKD 719,950。該批股份擬註銷。公司確認，所有股份回購均已獲得董事會正式授權批准，並遵守所有適用的上市規則、法律及其他監管規定。根據規則，公司在股份回購後的30天內，即截至2024年7月28日，將不會進行任何新股發行或庫存股份再出售或轉讓。
科濟藥業-B（02171.HK）於2024年6月28日提交了翌日披露報表，披露其已發行股份或庫存股份的變動情況。報告顯示，公司在2024年6月25日至6月28日期間，已發行股份數目保持不變，為575,653,415股。然而，在2024年5月31日至6月28日期間，公司進行了多次股份回購，總計回購股份數目為4,135,500股，佔已發行股份的0.7184%。最後一次回購發生在2024年6月28日，當日回購150,000股，每股購回價介於HKD 4.74至HKD 4.81之間，總支付價格為HKD 719,950。該批股份擬註銷。公司確認，所有股份回購均已獲得董事會正式授權批准，並遵守所有適用的上市規則、法律及其他監管規定。根據規則，公司在股份回購後的30天內，即截至2024年7月28日，將不會進行任何新股發行或庫存股份再出售或轉讓。
On June 28, 2024, China Shiji Pharmaceutical Co., Ltd-B (02171.HK) submitted a report to be disclosed the following day, disclosing changes in its issued or treasury stock holdings. The report shows that from June 25 to June 28, 2024, the number of issued shares of the company remained unchanged at 575,653,415 shares. However, between May 31 and June 28, 2024, the Company carried out multiple share repurchases, with a total of 4,135,500 shares repurchased, accounting for 0.7184% of the issued shares. The last repurchase took place on June 28, 2024, with a repurchase of 150,000 shares at a repurchase price per share ranging from HKD 4.74 to HKD 4.81, with a total payment of HKD 719,950. The shares are intended to be cancelled. The company confirms that all share repurchases have been formally authorized by the board of directors and comply with all applicable listing rules, laws and other regulatory requirements. According to the rules, within 30 days after the share repurchase, namely by July 28, 2024, the Company will not issue any new shares or resell or transfer treasury stock holdings.
On June 28, 2024, China Shiji Pharmaceutical Co., Ltd-B (02171.HK) submitted a report to be disclosed the following day, disclosing changes in its issued or treasury stock holdings. The report shows that from June 25 to June 28, 2024, the number of issued shares of the company remained unchanged at 575,653,415 shares. However, between May 31 and June 28, 2024, the Company carried out multiple share repurchases, with a total of 4,135,500 shares repurchased, accounting for 0.7184% of the issued shares. The last repurchase took place on June 28, 2024, with a repurchase of 150,000 shares at a repurchase price per share ranging from HKD 4.74 to HKD 4.81, with a total payment of HKD 719,950. The shares are intended to be cancelled. The company confirms that all share repurchases have been formally authorized by the board of directors and comply with all applicable listing rules, laws and other regulatory requirements. According to the rules, within 30 days after the share repurchase, namely by July 28, 2024, the Company will not issue any new shares or resell or transfer treasury stock holdings.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Heat List
    US
    SymbolLatest Price% Chg

    No Data

    Hot News
    Updated